Nurse Practitioner Program year 2022 Source: CMS Open Payments, 2026 publication

Helen Alexandroff

Clinical Nurse Specialist, Adult Health New York, NY Nurse Practitioner

NPI 1437563285 CMS profile 10918541

1 Gustave Levy Place, New York, NY 10029

Open in the dashboard

General payments

$125

1 record reported · program year 2022

Research payments

$0

Paid to them · None reported · program year 2022

Ownership & investment interest

$0

None reported

Through program year 2022, Helen Alexandroff of New York, NY is reported in the CMS Open Payments database as having received $125 across 1 general payment and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 31st percentile of Clinical Nurse Specialist, Adult Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2022 General $125 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Helen Alexandroff
  • Clinical Nurse Specialist, Adult Health median
  • Middle half of Clinical Nurse Specialist, Adult Health
  • National median

In program year 2025, general payments to Helen Alexandroff were reported at $0. Among 446 Clinical Nurse Specialist, Adult Health profiles paid that year, the median was $193 and the middle half received between $61 and $597.

Show as a table
Year Helen Alexandroff Clinical Nurse Specialist, Adult Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $0 $133 $48–$445 $132
2022 $125 $163 $57–$526 $149
2023 $0 $173 $64–$597 $160
2024 $0 $171 $54–$575 $164
2025 $0 $193 $61–$597 $169

Breakdown

Who paid General payments · program year 2022
  1. Novo Nordisk Inc $125 1 payment

Every payment, record by record

What the payments were for General payments · program year 2022
  1. Food and Beverage $125 1 payment
Products named General payments · program year 2022
  1. Ozempic $125 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

155

Median for Certified Clinical Nurse Specialist: 344

Drug cost

$651

Median for Certified Clinical Nurse Specialist: $20,739

Branded share of claims

0%

Median for Certified Clinical Nurse Specialist: 20.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pantoprazole Sodium Generic 29 $171
Metoprolol Tartrate Generic 33 $146
Furosemide Generic 35 $82
Amiodarone Hcl Generic 11 $78
Atorvastatin Calcium Generic 14 $69
Oxycodone Hcl Generic 19 $60
Potassium Chloride Generic 14 $45

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,644 Part D prescribers listed as Certified Clinical Nurse Specialist; they describe a distribution and say nothing about conduct.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Nurse Specialist, Adult Health in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record